Delivery Order SPE2DX22D0010-SPE2D825FJD17
- Not listed
- This delivery order, awarded on October 20, 2025, represents a $37,570.40 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply products. The contract, which is not set-aside and was competitively awarded, is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- On September 17, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $67,967.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,567.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with completion scheduled for September 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $25,366.32 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award, issued under delivery order contract number 4569090857, represents a child contract action supporting pharmaceutical and medical supply procurement for federal military and healthcare systems. The place of performance is...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $79,379.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The contract will...
- On October 22, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed price delivery order valued at $2,775.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-set-aside delivery order, with an ultimate completion date of October 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a $1,223.64 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 13, 2025, with a completion deadline of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,173.44 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This delivery order, awarded on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain division, represents a $14,151.30 firm fixed-price contract with AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order carries no...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $11,176.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 27, 2025, with completion targeted for October 28, 2025. This non-set-aside competitive award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle running through December 2026. AmerisourceBergen,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJD17Delivery Order
This delivery order, issued by the Defense Logistics Agency Medical Supply Chain on September 5, 2025, awards $1,022.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply deliverables with completion expected by September 8, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award to this established federal vendor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical products to federal healthcare systems, including the military and veteran care networks. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime vendor agreement enables the company to supply a comprehensive range of pharmaceuticals and medical commodities—including specialty medications, vaccines, generic and brand-name drugs, and medical devices—to support military healthcare operations globally. The delivery order falls within this broader pharmaceutical prime vendor framework, which allows AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through flexible procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/5/25 |